back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2019-01-10 Tx date 2018-07-19 |
$GSD
Devonian Health Group Inc. |
Aspri Pharma Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Subordinate Voting Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-01-10 Tx date 2018-07-19 |
$GSD
Devonian Health Group Inc. |
Aspri Pharma Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
8,097,777 | ||
| Filed 2019-01-10 Tx date 2018-07-19 |
$GSD
Devonian Health Group Inc. |
Aspri Pharma Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-01-10 Tx date 2018-07-19 |
$GSD
Devonian Health Group Inc. |
Aspri Pharma Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Subordinate Voting Shares
00 - Opening Balance-Initial SEDI Report
|
8,097,777 | ||
| Filed 2018-07-24 Tx date 2018-07-19 |
$GSD
Devonian Health Group Inc. |
Aspri Pharma Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Convertible Debentures Convertibles en actions droit de vote sulbalternes (10%)
16 - Acquisition or disposition under a prospectus exemption
|
$
+$1,333,333 vol $0.75 each |
$1,333,333 | |
| Filed 2018-07-24 Tx date 2018-07-19 |
$GSD
Devonian Health Group Inc. |
Aspri Pharma Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Convertible Debentures Convertibles en actions droit de vote sulbalternes (10%)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-07-23 Tx date 2018-07-19 |
$GSD
Devonian Health Group Inc. |
Aspri Pharma Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Subordinate Voting Shares
00 - Opening Balance-Initial SEDI Report
|
8,403,361 | ||
| Filed 2018-07-23 Tx date 2018-07-19 |
$GSD
Devonian Health Group Inc. |
Aspri Pharma Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
8,403,361 |